User: prashantiyengar Topic: IP
Category: drugs :: india
1 new since Aug 23 2017 12:02 IST RSS 2.0
 
1 to 20 of 2,798    
India grants Pfizer patent for pneumonia vaccine; health groups say disease treatment will be out of reach for poor 22.8.2017 DNA: Wide Angle
India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations. The decision by India's patent office bars other companies from making cheaper copies of the vaccine and allows Pfizer to exclusively sell it in India until 2026. It's a big victory for the U.S. drugmaker in a market that has the world's largest number of pneumonia cases, a lung disease that kills nearly a million children a year globally. The decision also has international implications, as several poorer nations rely on India's robust drugs industry to supply cheaper copies of medicines and vaccines. It also comes at a time of ongoing U.S. pressure on India to tighten its patent laws. The United States Trade Representative expressed concerns about India's intellectual property laws in a report in June, and listed it among countries whose IP laws unfairly favour local companies. Pfizer's vaccine protects ...
Also found in: [+]
Indian patent office grants patent to Pfizer on pneumonia vaccine 22.8.2017 TOI: India
Also found in: [+]
India grants Pfizer patent on pneumonia vaccine in blow to aid group 22.8.2017 TOI: Intl Business
PFIZER-INDIA/VACCINE (UPDATE 1):UPDATE 1-India grants Pfizer patent on pneumonia vaccine in blow to aid group
Also found in: [+]
India grants Pfizer patent for blockbuster brand Prevenar 13 22.8.2017 ET: Pharma
India has seven pneumonia related deaths per 1,000 live births, according to the 2016 Pneumonia and Diarrhea Progress Report.
Also found in: [+]
Pfizer revenue misses on lower Prevnar, Enbrel sales 1.8.2017 TOI: Intl Business
PFIZER-RESULTS/ (UPDATE 2):UPDATE 2-Pfizer revenue misses on lower Prevnar, Enbrel sales
Also found in: [+]
Adviser charged with insider trading on Pfizer-King deal pleads guilty 26.7.2017 TOI: Intl Business
USA-INSIDERTRADING/PFIZER:Adviser charged with insider trading on Pfizer-King deal pleads guilty
Also found in: [+]
Merck, Samsung Bioepis launch discounted U.S. Remicade alternative 24.7.2017 TOI: Intl Business
SAMSUNG BIOEPIS-JOHNSON&JOHNSON/REMICADE (UPDATE 1, PIX):UPDATE 1-Merck, Samsung Bioepis launch discounted U.S. Remicade alternative
Also found in: [+]
EU medicines agency recommends approval of Novartis leukaemia drug Rydapt 21.7.2017 TOI: Intl Business
NOVARTIS-LEUKEMIA/APPROVAL (URGENT):EU medicines agency recommends approval of Novartis leukaemia drug Rydapt
Also found in: [+]
FDA tentatively approves Merck's copycat of Sanofi's Lantus 20.7.2017 TOI: Intl Business
MERCK & CO-FDA/:FDA tentatively approves Merck's copycat of Sanofi's Lantus
Also found in: [+]
Nikkei falls to more than 1-week lows as cyclical stocks weigh; Toshiba jumps 18.7.2017 TOI: Intl Business
JAPAN-STOCKS/MIDDAY:Nikkei falls to more than 1-week lows as cyclical stocks weigh; Toshiba jumps
Also found in: [+]
Indian Pharma exports to USA may go up in 2017-18: Report 17.7.2017 ET: Pharma
The Indian Pharmaceuticals Industry (IPI) earns around 70 per cent of its revenues from sale of generic drugs and generates around 50 per cent of its revenues from exports.
Also found in: [+]
EU regulators charge Teva over pay-for-delay drug deal 17.7.2017 TOI: Intl Business
EU-TEVA PHARM IND/ANTITRUST (UPDATE 2):UPDATE 2-EU regulators charge Teva over pay-for-delay drug deal
Also found in: [+]
Novartis readies for FDA review of $1 bln CAR-T child cancer hope 11.7.2017 TOI: Intl Business
NOVARTIS-CANCER/:Novartis readies for FDA review of $1 bln CAR-T child cancer hope
Also found in: [+]
Modi urged to remain committed to affordable drugs during meeting with Trump 24.6.2017 TOI: India
Also found in: [+]
Modi urged to remain committed to affordable dedicines during meeting with Trump 23.6.2017 TOI: India
Also found in: [+]
How a leadership flux, and consequent tinkering in strategy has taken a toll on Cipla 13.6.2017 ET: Pharma
Heads of Europe and US operations Frank Pieters and Tim Crew are both gone, as is Subhanu Saxena, the MD who was hired from Novartis in 2012.
Also found in: [+]
Transfer of IP assets by pharma firms to abroad under RBI scrutiny 29.5.2017 ET: Pharma
Several pharma cos including some of the leading ones have over the years steadily transferred most of their IPs outside India and reduced their tax burden in the country.
Also found in: [+]
Roche vs Indian Pharma: The battle for a cheaper cancer drug 14.5.2017 ET: Pharma
The companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first woman pharma-billionaire, Kiran Mazumdar-Shaw.
Also found in: [+]
'India's IPR policy a good first step, needs to address gaps' 13.5.2017 ET: Policy
Both, the companies in the United States and the Trump administration have been expressing concerns over some aspects of the Indian IPR policy.
Also found in: [+]
Doctors fear pharmacists will push for generic drugs that give max profit 1.5.2017 ET: Pharma
Generic drugs sold under a brand name given by the manufacturer are called branded generics. In India, 90% of the pharma market is made up of such branded generic drug
Also found in: [+]
1 to 20 of 2,798